Delivery Order SPE2DE24D0013-SPE2D626F51F5
- Not listed
- On December 22, 2025, the Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $6,800 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement activity under a larger indefinite delivery contract and is scheduled for completion by December 30, 2025. The award carries no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $3,740 on October 26, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as XPCOV2/FLU/RSV-10, is structured as a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and carries no set-aside designation. This delivery order represents a continuation of Cepheid's extensive federal...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $10,000 firm fixed-price delivery order on November 24, 2025, for COVID-19, influenza, and respiratory syncytial virus diagnostic supplies. The delivery order, valued at the ceiling amount, is scheduled for completion by December 2, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order carries no set-aside designation and represents a continuation of Cepheid's...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- This delivery order, valued at $34,225.20, was awarded on December 8, 2025, by the Defense Logistics Agency's Medical Supply Chain to Cepheid Inc. for molecular diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus detection. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by December 15, 2025. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $3,638 for COVID-19/Influenza/RSV diagnostic supplies. The delivery order, issued on December 10, 2025, with an ultimate completion date of December 24, 2025, represents a routine procurement action under the DLA Medical Supply Chain's established contracting framework for infectious disease testing solutions. No...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $5,440 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on May 6, 2025, with an ultimate completion date of May 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus detection. The award carries no set-aside designation and represents a continuation...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $4,080 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 18, 2025. The delivery order, designated 4569971783 and titled XPCOV2/FLU/RSV-10, procures diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a $4,198.65 firm fixed-price delivery order (Contract No. 4569971781) from the Defense Logistics Agency Medical Supply Chain on November 10, 2025, for respiratory pathogen diagnostic supplies related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The delivery order is scheduled for completion by November 18, 2025, and carries no set-aside designation. The award...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F51F5Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc. on December 22, 2025, for diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus detection. The delivery order, which extends through December 30, 2025, represents a continuation of the federal government's reliance on Cepheid's molecular diagnostic capabilities. Cepheid, headquartered in Sunnyvale, California, is a leading manufacturer of advanced molecular diagnostic systems and reagents, with particular expertise in its GeneXpert diagnostic platform for detecting infectious diseases. This procurement includes no set-aside designation, reflecting open competition in the federal molecular diagnostics market. This award represents one of numerous delivery orders issued to Cepheid across multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. Cepheid currently maintains two significant Indefinite Delivery Contracts with the Veterans Affairs system, including a $32.8 million contract with VISN 6 extending through September 30, 2030, and a $6.7 million contract with VISN 17 extending through December 28, 2029. These frameworks enable continuous procurement of diagnostic reagents, test kits, and associated services to support federal clinical laboratory operations and infectious disease testing across the distributed network of VA medical centers and integrated service networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 12/21/25 |